Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 7 subfamily E member 130 pseudogene (OR7E130P, alias OST702) is a human pseudogene designated by multiple authorities including HGNC and NCBI[1][4][8]. It is a member of the olfactory receptor gene family, which encodes proteins involved in odorant molecule recognition and subsequent neuronal signal transduction via G protein-coupled receptor mechanisms[3][7]. However, as a pseudogene, OR7E130P does not encode a functional protein and therefore does not play a role in odorant signaling or other biological processes[3]. Pseudogenes like OR7E130P are derived from once-functional genes but have accumulated mutations that prevent them from producing active proteins. They are not considered therapeutic targets, as they lack biological function and are not implicated in disease or drug interaction. There are no known biomarkers, disease associations, mechanisms of action, or safety concerns relevant to this pseudogene, and there is no evidence for drug interaction or therapeutic relevance in current databases[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 7 subfamily E member 130 pseudogene (OR7E130P).